Oncolytics Biotech

$3.99
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.36 (+9.91%) As of 5:21 PM UTC today

Why Robinhood?

You can buy or sell ONCY and other stocks, options, and ETFs commission-free!

About ONCY

Oncolytics Biotech, Inc. engages in the development of immuno-oncolytic virus for the treatment of solid tumors and hematological malignancies. It offers a non-pathogenic, properietary isolate of the reovirus that induce selective tumor lysis, and promotes an inflamed tumor phenotype through innate and adaptive immune responses. The company was founded by Matthew C. Coffey and Bradley George Thompson on April 2, 1998 and is headquartered in Calgary, Canada. The listed name for ONCY is Oncolytics Biotech, Inc. Common Shares.

CEO

Matthew C. Coffey

Employees

Headquarters

Calgary, Alberta

Founded

1998

Market Cap

174.49M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

2.36M

High Today

$4.05

Low Today

$3.63

Open Price

$3.64

Volume

1.38M

52 Week High

$6.02

52 Week Low

$0.94

Collections

ONCY Earnings

-$0.71

-$0.47

-$0.24

$0.00

Q1 FY19

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Expected Mar 4, After Hours